According to IMARC Group latest report titled” 3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is currently witnessing strong growth. The global 3D Bioprinting Market to exhibit moderate growth during the next five years. 3D bioprinting represents an additive manufacturing technique used for developing precise anatomical tissues through the decomposition of cell-based bio-inks. It involves several processes, including direct and laser writing, microstamping, stereolithography, electro-printing, photolithography, inkjet deposition, etc. The bio-inks are produced using living cells, biomaterials, active biomolecules, etc., to generate 3D structures of the tissues and organs. The printer deposits numerous layers of biomaterials to build complex bodily structures, such as bones, vascular grafts, skin, tracheal splints, cartilages, etc. 3D bioprinting assembles and binds these components with dissolvable gel or collagen scaffolds to support and mold the cells into the desired shape.
Request to get the sample report: https://www.imarcgroup.com/3d-bioprinting-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Trends:
The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive RD investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth.
View Full Report with TOC List of Figure: https://www.imarcgroup.com/3d-bioprinting-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- 3D Systems Inc.
- Aspect Biosystems Ltd.
- Cellink, Cyfuse Biomedical K.K.
- EnvisionTEC GmbH (Desktop Metal Inc.)
- GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
- Materialise
- Organovo Holdings Inc.
- Poietis, RegenHU
- Stratasys Ltd
3D Bioprinting Market Segmentation:
Our report has categorized the market based on region, component, application and end use industry.
Breakup by Component:
- 3D Bioprinters
- Syringe/Extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
- Scaffolds
- Biomaterials
- Living Cells
- Hydrogels
- Extracellular Matrices
- Others
Breakup by Application:
- Research
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical
- Skin
- Bone and Cartilage
- Blood Vessels
- Others
Breakup by End User:
- Hospitals
- Research Organization and Academic Institutes
- Biopharmaceuticals Companies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
